Ethical issues relating the the banking of umbilical cord blood in Mexico.
BACKGROUND
Umbilical cord banks are a central component, as umbilical cord tissue providers, in both medical treatment and scientific research with stem cells. But, whereas the creation of umbilical cord banks is seen as successful practice, it is perceived as a risky style of play by others. This article examines and discusses the ethical, medical and legal considerations that arise from the operation of umbilical cord banks in Mexico.


CONCLUSIONS
A number of experts have stated that the use of umbilical cord goes beyond the mere utilization of human tissues for the purpose of treatment. This tissue is also used in research studies: genetic studies, studies to evaluate the effectiveness of new antibiotics, studies to identify new proteins, etc. Meanwhile, others claim that the law and other norms for the functioning of cord banks are not consistent and are poorly defined. Some of these critics point out that the confidentiality of donor information is handled differently in different places. The fact that private cord banks offer their services as "biological insurance" in order to obtain informed consent by promising the parents that the tissue that will be stored insures the health of their child in the future raises the issue of whether the consent is freely given or given under coercion. Another consideration that must be made in relation to privately owned cord banks has to do with the ownership of the stored umbilical cord.


CONCLUSIONS
Conflicts between moral principles and economic interests (non-moral principles) cause dilemmas in the clinical practice of umbilical cord blood storage and use especially in privately owned banks. This article presents a reflection and some of the guidelines that must be followed by umbilical cord banks in order to deal with these conflicts. This reflection is based on the fundamental notions of ethics and public health and seeks to be a contribution towards the improvement of umbilical cord banks' performance.
Serrano-Delgado
V Moises
VM
Obstetrics and Gynaecology Hospital with Family Medicine # 13, Mexican Institute of Social Security, Mexico City, Mexico. vsmd@hotmail.com
Novello-Garza
Barbara
B
Valdez-Martinez
Edith
E
D026686:Beneficence; D001771:Blood Banks / Q000191:economics / Q000941:ethics* / Q000331:legislation & jurisprudence*; D001782:Blood Donors; D001793:Blood Preservation / Q000941:ethics; D016265:Conflict of Interest; D036101:Cord Blood Stem Cell Transplantation / Q000941:ethics; D003362:Cost-Benefit Analysis; D026689:Ethical Analysis; D005062:European Union; D005312:Fetal Blood; D006801:Humans; D007258:Informed Consent / Q000941:ethics; D008800:Mexico; D028681:Moral Obligations; D010067:Ownership / Q000941:ethics; D026684:Personal Autonomy; D017149:Private Sector / Q000941:ethics; D011640:Public Policy; D017150:Public Sector / Q000941:ethics; D012935:Social Justice; D014182:Transplantation, Autologous
J Perinat Med. 2007;35(4):314-21
17511596
Haematologica. 2009 Apr;94(4):536-41
19229051
An Sist Sanit Navar. 2006;29 Suppl 2:15-24
17469237
Stem Cells. 2007 Jan;25(1):107-14
16973833
Pediatrics. 2007 Jan;119(1):165-70
17200285
Biol Blood Marrow Transplant. 2008 Mar;14(3):356-63
18275904
Arch Pediatr. 2005 Mar;12(3):298-304
15734129
An Sist Sanit Navar. 2004 Jan-Apr;27(1):77-85
15146208
Transfusion. 2008 Feb;48(2):228-36
18028272
JAMA. 2007 Feb 14;297(6):576
17299186
N Engl J Med. 2000 Jun 22;342(25):1846-54
10861319
Hematology Am Soc Hematol Educ Program. 2007;:55-61
18024609
Pediatrics. 2009 Mar;123(3):1011-7
19255033
Br Med J (Clin Res Ed). 1985 Apr 13;290(6475):1117-9
3157420
Blood. 2005 May 15;105(10):3786-92
15677563
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):538-43
15982697
Biol Blood Marrow Transplant. 2008 Mar;14(3):316-22
18275898
Hematology Am Soc Hematol Educ Program. 2005;:377-83
16304407
Obstet Gynecol. 2005 Dec;106(6):1393-407
16319269
Pediatrics. 1999 Jul;104(1 Pt 1):116-8
10390273